<?xml version="1.0" encoding="UTF-8"?>
<ref id="zoi201035r13">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <person-group>
   <name name-style="western">
    <surname>Kuerer</surname>
    <given-names>HM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rauch</surname>
    <given-names>GM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Krishnamurthy</surname>
    <given-names>S</given-names>
   </name>, 
   <etal/>
  </person-group>
  <article-title>A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eiminated following neoadjuvant systemic therapy</article-title>. 
  <source>Ann Surg</source>. 
  <year>2018</year>;
  <volume>267</volume>(
  <issue>5</issue>):
  <fpage>946</fpage>-
  <lpage>951</lpage>. doi:
  <pub-id pub-id-type="doi">10.1097/SLA.0000000000002313</pub-id>
  <?supplied-pmid 28549010?>
  <pub-id pub-id-type="pmid">28549010</pub-id>
 </mixed-citation>
</ref>
